Cypress Wealth Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$711K Sell
1,778
-14
-0.8% -$5.59K 0.08% 183
2026
Q2
$693K Sell
1,792
-134
-7% -$49.7K 0.09% 181
2026
Q1
$564K Buy
+1,926
New +$633K 0.08% 203
2025
Q4
– Sell
-972
Closed -$314K – 393
2025
Q3
$314K Buy
972
+41
+4% +$12.8K 0.05% 248
2025
Q2
$362K Sell
931
-38
-4% -$15.3K 0.06% 204
2025
Q1
$421K Buy
969
+173
+22% +$69.4K 0.09% 169
2024
Q4
$294K Buy
796
+117
+17% +$49K 0.06% 208
2024
Q3
$353K Buy
679
+23
+4% +$12.3K 0.07% 193
2024
Q2
$356K Buy
656
+64
+11% +$33.8K 0.08% 177
2024
Q1
$307K Buy
592
+22
+4% +$10.9K 0.07% 194
2023
Q4
$269K Buy
570
+31
+6% +$14.3K 0.07% 196
2023
Q3
$235K Buy
+539
New +$244K 0.07% 209
2022
Q3
– Sell
-444
Closed -$214K – 232
2022
Q2
$214K Buy
444
+7
+2% +$3.46K 0.07% 208
2022
Q1
$215K Buy
+437
New +$200K 0.06% 221

Other funds holding ELV

Cypress Wealth Services's ELV Position: Q3 2026 in Review

Cypress Wealth Services reduced its Elevance Health (ELV) stake by 0.78% in Q3 2026, selling an estimated $5.59K and leaving 1,778 shares worth $711K. The position accounts for 0.08% of the portfolio, ranked #183.

Cypress Wealth Services first reported a position in ELV in Q1 2022 and has held it in 14 quarters since. 1,621 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Cypress Wealth Services held 1,778 shares of Elevance Health worth $711K as of Q3 2026.
  • Cypress Wealth Services sold 14 Elevance Health shares in Q3 2026, an estimated $5.59K.
  • Elevance Health made up 0.08% of Cypress Wealth Services's portfolio in Q3 2026, its #183 holding.
  • Cypress Wealth Services first reported a position in Elevance Health in Q1 2022 and has held it in 14 quarters since.
  • 1,621 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Cypress Wealth Services's 13F filing for Q3 2026, filed 21 Oct 2026.